Next Article in Journal
Design and Evaluation of Novel Antimicrobial and Anticancer Agents Among Tetrazolo[1,5-c]quinazoline-5-thione S-Derivatives
Previous Article in Journal
Scientia Pharmaceutica, Autorenhinweise 2014
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 81
Issue 1
10.3797/scipharm.1202-03
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective

by
Dipika BANSAL
*,
Swathi MALLA
,
Kapil GUDALA
and
Pramil TIWARI
Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S Nagar, Punjab-160062, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(1), 1-14; https://doi.org/10.3797/scipharm.1202-03
Submission received: 7 February 2012 / Accepted: 9 October 2012 / Published: 9 October 2012
Versions Notes

Abstract

Growth of international free trade and inadequate drug regulation have led to the expansion of trade in counterfeit drugs worldwide. Technological protection is seen to be the best way to avoid this problem. Different technologies came into existence like overt, covert, and track and trace technologies. This review emphasises ideal technological characteristics, existing anti-counterfeit technologies, and their adoption in different countries. Developed countries like the USA have implemented RFID while the European trend is towards 2D barcodes. The Indian government is getting sensitised about the extent of the problem and has formulated rules mandating barcodes. Even the pharmaceutical companies have been employing these technologies in order to detain illegitimate drugs in their supply chain.
Keywords: Authentication; Anti-counterfeit technology; RFID; Pedigree; Serialization Authentication; Anti-counterfeit technology; RFID; Pedigree; Serialization

Share and Cite

MDPI and ACS Style

BANSAL, D.; MALLA, S.; GUDALA, K.; TIWARI, P. Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective. Sci. Pharm. 2013, 81, 1-14. https://doi.org/10.3797/scipharm.1202-03

AMA Style

BANSAL D, MALLA S, GUDALA K, TIWARI P. Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective. Scientia Pharmaceutica. 2013; 81(1):1-14. https://doi.org/10.3797/scipharm.1202-03

Chicago/Turabian Style

BANSAL, Dipika, Swathi MALLA, Kapil GUDALA, and Pramil TIWARI. 2013. "Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective" Scientia Pharmaceutica 81, no. 1: 1-14. https://doi.org/10.3797/scipharm.1202-03

APA Style

BANSAL, D., MALLA, S., GUDALA, K., & TIWARI, P. (2013). Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective. Scientia Pharmaceutica, 81(1), 1-14. https://doi.org/10.3797/scipharm.1202-03

Article Metrics

Back to TopTop